Search clinical trials for: Coagulants

Total 4920 results

Oregon Health and Science University

Completed

FEIBA and Use of Blood Products in Cardiac Surgery (FEIBA)

Cardiovascular Disease

United States
Emory University
Takeda Pharmaceuticals North America, Inc.

Recruiting

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis (SAFE)

Hemophilia A

United States
Novo Nordisk A/S

Completed

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX (DOSE)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

United States
Mayo Clinic

Withdrawn

FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients

Cardiac Disease
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)

Hemophilia A or B With Inhibitors

Croatia, North Macedonia, Ukraine
Novo Nordisk A/S

Completed

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

United States
Baxalta now part of Shire

Completed

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Hemophilia A | Hemophilia B | Hemophilia A or B With Inhibitors

Poland, United States, Bulgaria, Romania, Japan, Russian Federation, New Zealand, Croatia, Ukraine, Brazil
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors (HAVEN 1)

Hemophilia A

Korea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
Sheba Medical Center

Completed

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

Hemophilia A
Rush University Medical Center
Advocate Health Care

Completed

Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed

Hemorrhage
Yale University

Completed

The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

Pleural Effusion | Thoracic Effusion

United States
The Hospital for Sick Children
Roche Pharma AG

Not yet recruiting

Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia

Hemophilia
Qianfoshan Hospital

Not yet recruiting

Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in Predicting the Incidence of Nausea and Vomiting

Hemophilia A

China
University of Yamanashi

Not yet recruiting

sCLEC-2 in Stroke Study (CLECSTRO)

Transient Ischemic Attack | Acute Ischemic Stroke

Japan
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients (TGANephrotic)

Nephrotic Syndrome

France
Aalborg University Hospital

Recruiting

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Infertility | Recurrent Miscarriage | Recurrent Implantation Failure | Recurrent Pregnancy Loss | Mannose-Binding Lectin Deficiency | Habitual Abortion | Recurrent Spontaneous Abortion

Denmark
Fundación Pública Andaluza para la gestión de la...

Recruiting

Hemostatic Patch/Collagen Sealant and Polyethylene Glycol (Hemopatch) in the Postoperative of the Thyroidectomy.

Goiter

Spain
National Cancer Institute (NCI)

Recruiting

Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19

COVID-19

United States
University Health Network, Toronto
McMaster University

Recruiting

Thrombin in Cardiac Surgery

Coagulation Disorder | Surgical Blood Loss | Hemostatic Disorder | Thrombin | Cardiovascular Surgical Procedures

Canada
University Hospital, Lille

Recruiting

QUANTRA® References Range Protocol in Pregnancy and Postpartum (QUANTRA®_GPP)

Pregnancy Postpartum

France
Prof. Dr. Dr. Thomas Hilberg

Recruiting

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis (CLHEAR)

Hemophilia A

Germany
The University of Texas Health Science Center,...

Recruiting

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Blood Coagulation Disorders, Inherited | Thrombotic Disorder

United States
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Thrombosis Outcomes in Pediatric Venous Thromboembolism (TOP)

Venous Thromboembolism

United States
BioMarin Pharmaceutical

Enrolling by invitation

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401) (GENEr8-LTE)

Hemophilia A

United Kingdom, United States
National Institute of Allergy and Infectious Diseases...

Enrolling by invitation

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Post Influenza

United States
Jubilee Mission Medical College and Research Institute

Completed

Hemostatic Variables In Snakebite Study (HISS)

Snake Bites | Coagulopathy, Consumption

India
Duke University
Medtronic - MITG

Terminated

Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip

Morbid Obesity

United States
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic
IRCCS Policlinico S. Donato

Active, not recruiting

Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic (COVID_OMICS)

Covid19 | Interstitial Pneumonia

Italy
Oregon Health and Science University

Completed

Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)

Hemophilia

United States
University Hospital, Lille
Ministry of Health, France

Completed

Innate Immunity Gene Polymorphisms and Yeast Colonization (Candigene)

Critical Illness

France
University Hospital, Montpellier

Completed

Screening for Bleeding Disorders in Children

Bleeding Disorder

France
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study (4D)

Suspected Deep Vein Thrombosis

Canada
ALDUS Study Group

Enrolling by invitation

Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS) (ALDUS)

Liver Cirrhosis

Japan
Second Affiliated Hospital, School of Medicine,...

Completed

The Efficacy and Safety of the Loading Dose of Tranexamic Acid in Scoliosis Surgery During Perioperative

Tranexamic Acid
Boston VA Research Institute, Inc.
University of Michigan; Emory University; Shire

Withdrawn

Improved Factor VIII Inhibitor Evaluation (IFIE)

Hemophilia A | Hemophilia

United States
University Hospital, Strasbourg, France

Completed

Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels (COVID-APE)

Covid-19 With Positive RT-PCR

France
Albert Einstein College of Medicine

Terminated

Sickle Cell Trait and the Risk of Venous Thromboembolism (SCT&DVT)

Thrombosis

United States
University of Vermont
Janssen Research & Development, LLC

Completed

Novel Biomarkers of Thrombotic Risk

Myocardial Infarction

United States
Hannover Medical School

Terminated

Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

Clotting Disorder Due to Plasma Exchange Therapy | Humoral Rejection After Kidney Transplantation

Germany
University of Aarhus
Aarhus University Hospital; University of Southern Denmark; Sygehus Lillebaelt; Hospital of South West Jutland

Completed

Thrombosis and Neurocognition in Klinefelter Syndrome

Thrombosis | Klinefelter Syndrome

Denmark
Pfizer

Completed

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Factor VIII Deficiency, Congenital | Hemophilia A, Congenital | Factor 8 Deficiency, Congenital | Autosomal Hemophilia A | Classic Hemophilia
Abbott Medical Devices

Completed

Angio-Seal Evolution Device Registry

Coronary Artery Disease | Coronary Heart Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Arterial Occlusive Disease

United States
Azienda Ospedaliero-Universitaria Careggi

Completed

Aortic Dissection Detection Risk Score Plus D-dimer in Suspected Acute Aortic Dissection (ADvISED)

Aortic Dissection

Germany, Italy, Brazil, Switzerland
Royal Free Hospital NHS Foundation Trust

Unknown

UK - EHL Outcomes Registry

Hemophilia A | Hemophilia B

United Kingdom
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Factor VIII Inhibitors

Hemophilia

Sweden
Centre Hospitalier Universitaire Vaudois

Completed

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease (POCHEMO)

Blood Coagulation Disorder | Congenital Heart Defect

Switzerland
National Institute of Neurological Disorders and...

Completed

Study of Abnormal Blood Clotting in Children With Stroke

Cerebrovascular Accident | Blood Coagulation Disorder | Abnormalities | Vascular Disease | Brain Disease

United States
University Health Network, Toronto

Completed

Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass

Cardiac Disease | Renal Disease

Canada
Northwell Health
Organon

Terminated

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Sperm DNA Impact on ART Outcomes

United States

Search clinical trials for: Coagulants

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations